Retained Earnings - Dizal Jiangsu Pharmaceutical Co Ltd (SSE:688192) - Alpha Spread
D

Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192

Watchlist Manager
Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
Watchlist
Price: 33.4 CNY -7.2%
Market Cap: 13.6B CNY
Have any thoughts about
Dizal Jiangsu Pharmaceutical Co Ltd?
Write Note

Dizal Jiangsu Pharmaceutical Co Ltd
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Dizal Jiangsu Pharmaceutical Co Ltd
Retained Earnings Peer Comparison

Comparables:
6160
1801
9926
603392
300122

Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
D
Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
Retained Earnings
-ÂĄ2.5B
CAGR 3-Years
N/A
CAGR 5-Years
-66%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Retained Earnings
-ÂĄ57.7B
CAGR 3-Years
-28%
CAGR 5-Years
-44%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Retained Earnings
-ÂĄ14.7B
CAGR 3-Years
-15%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
Retained Earnings
-ÂĄ1.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Retained Earnings
ÂĄ8.2B
CAGR 3-Years
70%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Retained Earnings
ÂĄ29.1B
CAGR 3-Years
35%
CAGR 5-Years
61%
CAGR 10-Years
48%

See Also

What is Dizal Jiangsu Pharmaceutical Co Ltd's Retained Earnings?
Retained Earnings
-2.5B CNY

Based on the financial report for Dec 31, 2023, Dizal Jiangsu Pharmaceutical Co Ltd's Retained Earnings amounts to -2.5B CNY.

What is Dizal Jiangsu Pharmaceutical Co Ltd's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
-66%

Over the last year, the Retained Earnings growth was -79%.

Back to Top